OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The emerging roles of m6A modification in liver carcinogenesis
Xue‐Yin Pan, Cheng Huang, Jun Li
International Journal of Biological Sciences (2020) Vol. 17, Iss. 1, pp. 271-284
Open Access | Times Cited: 38
Xue‐Yin Pan, Cheng Huang, Jun Li
International Journal of Biological Sciences (2020) Vol. 17, Iss. 1, pp. 271-284
Open Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Hypoxia-Responsive lncRNA AC115619 Encodes a Micropeptide That Suppresses m6A Modifications and Hepatocellular Carcinoma Progression
Qiangnu Zhang, Wei Teng, Lesen Yan, et al.
Cancer Research (2023) Vol. 83, Iss. 15, pp. 2496-2512
Open Access | Times Cited: 33
Qiangnu Zhang, Wei Teng, Lesen Yan, et al.
Cancer Research (2023) Vol. 83, Iss. 15, pp. 2496-2512
Open Access | Times Cited: 33
The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
Roles and therapeutic implications of m6A modification in cancer immunotherapy
Juan Pan, Tuxiong Huang, Zhenjun Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Juan Pan, Tuxiong Huang, Zhenjun Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification
Anastasiya Kostyusheva, Sergey Brezgin, Dieter Glebe, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 2264-2275
Open Access | Times Cited: 56
Anastasiya Kostyusheva, Sergey Brezgin, Dieter Glebe, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 2264-2275
Open Access | Times Cited: 56
FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA
Xiaojie Gan, Zhihui Dai, Chun-mei Ge, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 30
Xiaojie Gan, Zhihui Dai, Chun-mei Ge, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 30
Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Goh, et al.
Cancer and Metastasis Reviews (2022) Vol. 42, Iss. 3, pp. 741-764
Closed Access | Times Cited: 30
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Goh, et al.
Cancer and Metastasis Reviews (2022) Vol. 42, Iss. 3, pp. 741-764
Closed Access | Times Cited: 30
29 m6A-RNA Methylation (Epitranscriptomic) Regulators Are Regulated in 41 Diseases including Atherosclerosis and Tumors Potentially via ROS Regulation – 102 Transcriptomic Dataset Analyses
Ming Liu, Keman Xu, Fatma Saaoud, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-42
Open Access | Times Cited: 29
Ming Liu, Keman Xu, Fatma Saaoud, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-42
Open Access | Times Cited: 29
METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway
Runkun Liu, Guozhi Yin, Hang Tuo, et al.
Biology Direct (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 21
Runkun Liu, Guozhi Yin, Hang Tuo, et al.
Biology Direct (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 21
METTL3 Mediates Epithelial–Mesenchymal Transition by Modulating FOXO1 mRNA N6‐Methyladenosine‐Dependent YTHDF2 Binding: A Novel Mechanism of Radiation‐Induced Lung Injury
Yang Feng, Ping Yuan, Hongjuan Guo, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 17
Yang Feng, Ping Yuan, Hongjuan Guo, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 17
Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer
Shang Chen, Yan He, Xin Huang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Shang Chen, Yan He, Xin Huang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice
Xuan Su, Yan Shen, Yue Jin, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 39
Xuan Su, Yan Shen, Yue Jin, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 39
Comprehensive Analysis of the Transcriptome-Wide m6A Methylation Modification Difference in Liver Fibrosis Mice by High-Throughput m6A Sequencing
Fan Chang, Yanzhen Ma, Sen Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 36
Fan Chang, Yanzhen Ma, Sen Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 36
Role of N6-Methyladenosine (m6A) Methylation Regulators in Hepatocellular Carcinoma
Nanfang Qu, Xiaotong Bo, Bin Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
Nanfang Qu, Xiaotong Bo, Bin Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights
Zhuo Huang, Qinyan Yao, Shuang Ma, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Zhuo Huang, Qinyan Yao, Shuang Ma, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
HOXB4/METTL7B cascade mediates malignant phenotypes of hepatocellular carcinoma through TKT m6A modification
Enshuang Guo, Lei Li, Jiankun Yang, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access
Enshuang Guo, Lei Li, Jiankun Yang, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access
Emerging importance of m6A modification in liver cancer and its potential therapeutic role
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
Pan-cancer analysis of DLAT reveals it as a prognostic Biomarker involved in immune infiltration of liver hepatocellular carcinoma
Haitao Xu, Yiqun Ma, Lishi Shao, et al.
Journal of Cancer (2025) Vol. 16, Iss. 7, pp. 2167-2180
Open Access
Haitao Xu, Yiqun Ma, Lishi Shao, et al.
Journal of Cancer (2025) Vol. 16, Iss. 7, pp. 2167-2180
Open Access
The Role of N6-Methyladenosine Modified Circular RNA in Pathophysiological Processes
Mei Tang, Yonggang Lv
International Journal of Biological Sciences (2021) Vol. 17, Iss. 9, pp. 2262-2277
Open Access | Times Cited: 21
Mei Tang, Yonggang Lv
International Journal of Biological Sciences (2021) Vol. 17, Iss. 9, pp. 2262-2277
Open Access | Times Cited: 21
Emerging role of m6A modification in fibrotic diseases and its potential therapeutic effect
Wufei Ye, Xiongwen Lv, Songsen Gao, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115873-115873
Closed Access | Times Cited: 8
Wufei Ye, Xiongwen Lv, Songsen Gao, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115873-115873
Closed Access | Times Cited: 8
N6-methyladenosine (m6A) modification in hepatocellular carcinoma
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116365-116365
Open Access | Times Cited: 3
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116365-116365
Open Access | Times Cited: 3
Dendrobine alleviates oleic acid-induced lipid accumulation by inhibiting FOS/METTL14 pathway
Junpei Zhang, Hongyun Zhang, Ying Chen, et al.
Journal of Molecular Histology (2024) Vol. 55, Iss. 5, pp. 995-1007
Closed Access | Times Cited: 3
Junpei Zhang, Hongyun Zhang, Ying Chen, et al.
Journal of Molecular Histology (2024) Vol. 55, Iss. 5, pp. 995-1007
Closed Access | Times Cited: 3
Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model
Yue Zhang, Fanhong Zeng, M. Zeng, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 13, pp. 3554-3572
Open Access | Times Cited: 15
Yue Zhang, Fanhong Zeng, M. Zeng, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 13, pp. 3554-3572
Open Access | Times Cited: 15
N6-methyladenosine RNA modification in nonalcoholic fatty liver disease
Luo Ping, Shiqi Li, Jing Wei, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 12, pp. 838-848
Closed Access | Times Cited: 5
Luo Ping, Shiqi Li, Jing Wei, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 12, pp. 838-848
Closed Access | Times Cited: 5
BMP9-ID1 Pathway Attenuates N6-Methyladenosine Levels of CyclinD1 to Promote Cell Proliferation in Hepatocellular Carcinoma
Han Chen, Mingming Zhang, Jianhao Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 981-981
Open Access | Times Cited: 1
Han Chen, Mingming Zhang, Jianhao Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 981-981
Open Access | Times Cited: 1
